← Back to Search

Cultural-Social Engagement Programs for Suicidal Thoughts

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary Spanish-Speaker
Identify as Hispanic/Latino adult (age 18+)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 10 weeks
Awards & highlights

Study Summary

This trial is testing a new intervention to increase cultural-social engagement and decrease suicide risk among Spanish-speaking adults.

Who is the study for?
This trial is for Hispanic/Latino adults over 18 who primarily speak Spanish, are part of the UR health system, feel socially isolated or lonely, and have had suicidal thoughts recently. They must not be able to engage much culturally or socially and cannot have severe medical or mental conditions that affect their ability to consent.Check my eligibility
What is being tested?
The study tests a program called SOCIAL-ENGAGE designed to increase cultural-social engagement and reduce suicide risk among Spanish-speaking adults at risk for suicide. It involves optimizing the intervention with a small group first, then testing its effectiveness in a larger pilot randomized controlled trial (RCT).See study design
What are the potential side effects?
Since SOCIAL-ENGAGE is a behavioral intervention focusing on education and social activities rather than medication, it may not have typical 'side effects' but could include emotional discomfort or increased anxiety due to participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I primarily speak Spanish.
Select...
I am a Hispanic/Latino adult over 18.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cultural-Social Engagement (A)
Change in Cultural-Social Engagement (B)
Change in Cultural-Social Engagement (C)
+1 more
Secondary outcome measures
Change in Suicide Risk (A)
Change in Suicide Risk (B)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Social Engage (S-ENGAGE)Experimental Treatment1 Intervention
S-ENGAGE is a skills-based psychotherapy that focuses on helping patients engage in meaningful rewarding social activities. Subjects will receive 10 one-hour individual sessions of S-ENGAGE over 10 weeks.
Group II: The Healthy Lifestyles Education ProgramPlacebo Group1 Intervention
The healthy lifestyles education program consists of a notebook containing evidence-based educational material on mental health, physical activity, and information on community resources. Study staff meet with participants once, individually, for 1 hour to review each section and answer questions participants might have.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
845 Previous Clinical Trials
534,952 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,799 Previous Clinical Trials
2,661,099 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
240 Patients Enrolled for Suicidal Thoughts

Media Library

Social Engage (S-ENGAGE) Clinical Trial Eligibility Overview. Trial Name: NCT05244733 — N/A
Suicidal Thoughts Research Study Groups: Social Engage (S-ENGAGE), The Healthy Lifestyles Education Program
Suicidal Thoughts Clinical Trial 2023: Social Engage (S-ENGAGE) Highlights & Side Effects. Trial Name: NCT05244733 — N/A
Social Engage (S-ENGAGE) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05244733 — N/A
~15 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top